Eiger BioPharmaceuticals, Inc.: 25-NSE filed Apr 25, 2024

Form type

25-NSE

Filing date

Apr 25, 2024

Accession number

0001354457-24-000305

Filer

Eiger BioPharmaceuticals, Inc. (CIK 1305253)